SUBLICENSE AGREEMENT By and Between ALSERES PHARMACEUTICALS, INC. and NAVIDEA BIOPHPARMACEUTICALS, INC.Sublicense Agreement • August 6th, 2012 • Navidea Biopharmaceuticals, Inc. • In vitro & in vivo diagnostic substances • New York
This Sublicense Agreement (the “Agreement”), dated as of this 31st day of July, 2012 (the “Effective Date”), is by and between Alseres Pharmaceuticals, Inc. (PKA Boston Life Sciences, Inc.), a Delaware corporation with offices at 239 South Street, Hopkinton, MA 01748 (“ALSE”), and Navidea Biopharmaceuticals, Inc., a Delaware corporation with offices at 425 Metro Place North, Suite 450, Dublin, Ohio 43017 (“NAVB”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • August 6th, 2012 • Navidea Biopharmaceuticals, Inc. • In vitro & in vivo diagnostic substances • New York
This Agreement is being entered into pursuant to the Sublicense Agreement dated as of the date hereof between NAVB and ALSE.
